Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
2.745
+0.155 (5.98%)
At close: May 16, 2025, 4:00 PM
2.740
-0.005 (-0.18%)
After-hours: May 16, 2025, 4:05 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $234.49 million as of May 16, 2025. Its market cap has decreased by -27.69% in one year.
Market Cap
234.49M
Enterprise Value
-189.50M
1-Year Change
-27.69%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $234.49M, a decrease of -87.90%. That is a compound annual growth rate of -37.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 234.49M | -17.13% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |